Viewing Study NCT03682705


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2026-03-02 @ 8:29 PM
Study NCT ID: NCT03682705
Status: COMPLETED
Last Update Posted: 2021-05-03
First Post: 2018-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis (RA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Elsubrutinib View
None ABBV-105 View
None Upadacitinib View
None ABBV-599 View
None Rheumatoid Arthritis View